More blood pressure medication recalled: Company recalls 80 lots of valsartan over cancer concerns

Aurobindo Pharma USA, Inc. is voluntarily recalling valsartan tablets that might include N-nitrosodiethylamine (NDEA), a possible human carcinogen.